Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Tagrisso Approved in the EU for the Adjuvant Treatment of Patients with Early-stage EGFR-mutated Lung Cancer
AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult […]
Portable ECG Device to be Further Rolled Out After Successful Pilot
A portable ECG monitoring device that detects heart irregularities is to be rolled out across […]
Novartis and Molecular Partners Announce Start of EMPATHY Clinical Trial for Ensovibep for the Treatment of COVID-19
Novartis and Molecular Partners announced today the start of the clinical trial EMPATHY, a Phase […]
Common Anti-inflammatory Drug Could Boost Cancer Immunotherapy
Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power […]
Ibex Receives CE Mark for AI Breast Cancer Solution
Ibex Medical Analytics, an AI-powered cancer diagnostics firm, has received the CE mark for the […]
Moderna Announces TeenCOVE Study of COVID-19 Vaccine (mRNA-1273) in Adolescents Meets Primary Endpoint
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US
Prosit Sole Biotechnology, a clinical-stage biotech company developing novel protein therapeutics, today announces that it […]
Study into Whether Vaccination of Previously Infected Generates Stronger, Broader Coronavirus Antibody Response
NHS Blood and Transplant (NHSBT) is carrying out a study in the Birmingham region aimed […]
InterSystems and Oncodesign Partner for the Optimization of Data Use to Enhance and Accelerate Drug Discovery Processes in Oncologyery Processes in Oncology
InterSystems, a leader in healthcare data management, and Oncodesign (Paris:ALONC), a biopharmaceutical company specializing in precision medicine, […]
European Commission Approves Venclyxto-based Combinations for Adults with Newly Diagnosed Acute Myeloid Leukaemia Who Are Ineligible for Intensive Chemotherapy
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Venclyxto […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more